“The regulatory perspective: benefits and limits of 3D printed drugs” – Presented by Dr. William Shang, Johnson & Johnson

Dr. William Shang

“The regulatory perspective: benefits and limits of 3D printed drugs” – Presented by Dr. William Shang, Johnson & Johnson. 3DP technology is already up and running in many areas. The future definitely looks promising when considering the idea of 3DPs, but are the regulatory agencies ready for such technology? The presentation will reflect the regulators views and concerns about pharmaceutical development, manufacturing and control of this new technology. Potential clinical and preclinical obstacles in terms of practical use will be addressed as well.

About Dr. William Shang Continue reading ““The regulatory perspective: benefits and limits of 3D printed drugs” – Presented by Dr. William Shang, Johnson & Johnson”

“Legal Issues around 3D Printed Drugs” – Presented by An Vijverman, Dewallens & Partners Law Firm

“Legal Issues around 3D Printed Drugs” – Presented by Ann Vijverman, Dewallens & Partners Law Firm.In this presentation it will be analyzed whether and how 3D printed Drugs could fit within the actual legal framework concerning medicinal products: can the 3D printed drug qualify as an industrially prepared medicinal product; or as a magistral or officinal formula; or as an ATMP; or as a bona fida unsolicited order; or …? And what about the applicable GMP requirements? And how will 3D drug printing comply with the applicable data protection legislation? Continue reading ““Legal Issues around 3D Printed Drugs” – Presented by An Vijverman, Dewallens & Partners Law Firm”

“Printing technologies in fabrication of drug delivery systems” – Presented by Niklas Sandler, Åbo Akademi University

Different types of printing methods have attracted interest as emerging technologies for fabrication of drug delivery systems (DDS). Recent examples include the use of diverse types of inkjet (IJ) printers for depositing drug-loaded inks to produce accurately and precisely dosed units of active pharmaceutical ingredients (APIs The concepts include on the simplest level accurately deposited doses of drug substances and one-layer films. On the other hand, printing technologies allow the manufacture of advanced multi-layer membranes, various type of stacked systems, and integrated multi-compartment systems with bioactive components. This talk will present examples on the use of printing technologies that are of potential interest in printing technologies in personalization of drug products. Continue reading ““Printing technologies in fabrication of drug delivery systems” – Presented by Niklas Sandler, Åbo Akademi University”

Tobias D. Gantner, MD, MBA, LL. M., HealthCare Futurists GmbH, will Speak at the 3D Medicines Printing Conference on “Imprintables: A new class of products empowering patients, physicians and consumers alike.”

Tobias D. Gantner, MD, MBA, LL. M., HealthCare Futurists GmbH, will Speak at the 3D Medicines Printing Conference on “Imprintables: A new class of products empowering patients, physicians and consumers alike.”

With the IoT, subjects that belong together finally come closer together. The medically interested public and a growing number of patients have gotten used to wearables and ubiquitous computing. Physicians, sick funds and governmental bodies are slowly adapting data usage generated from microelectronics.

The medical innovation reformation also brings the maker-scene to prostheses engineering, employing 3D printing technology. 3D printing of medicines has shown first successes and yet is still a far cry from putting pharmacy’s business models in jeopardy. Continue reading “Tobias D. Gantner, MD, MBA, LL. M., HealthCare Futurists GmbH, will Speak at the 3D Medicines Printing Conference on “Imprintables: A new class of products empowering patients, physicians and consumers alike.””

3D printing a functional polypill: a practical manufacturing method?”, Presented by Clive Roberts, University of Nottingham

3D printing a functional polypill: a practical manufacturing method?”, Presented by Clive Roberts, University of Nottingham. The processes used to produce tablets, the dominant form of medicine taken by patients, have changed relatively little for over a century. Whilst these approaches serve the industry and patients very well they remain limited and cannot create complex dosage forms or bespoke medications tailored for an individual or sub-population. This would be valuable in meeting therapeutic challenges and the need for personalized medicines. 3D printing, offers a route to address these issues. As an example I will show amongst other examples, a 3DP 5-drug polypill. The potential and challenges for using 3DP in the manufacture of medicines will be discussed. Continue reading “3D printing a functional polypill: a practical manufacturing method?”, Presented by Clive Roberts, University of Nottingham”

“Adding biomolecular recognition capability to 3D printed objects: 4D printing” – Presented by Céline A. Mandon, 3d.FAB – Université Lyon 1

Adding biomolecular recognition capability to 3D printed objects: 4D printing – Presented by Céline A. Mandon, 3d.FAB – Université Lyon 1. The availability of new printing technologies and materials, in additive manufacturing processes and more specifically 3D printing, initiate profound mutation of biotechnology engineers’ way of thinking. Our group have been working on this new paradigm for the last 2 years, digging deeply into the 3D printing technologies and ink formulation to achieve complex 3D objects, composed of printed living cells evolving into human tissues or photopolymers bearing biomolecules. These 4D printed objects, by the access to unprecedented sensing layer complex geometries, generate biological diagnostic devices such as immunosensors but also enzymatically active 3D objects for biosensing and catalysis.

Continue reading ““Adding biomolecular recognition capability to 3D printed objects: 4D printing” – Presented by Céline A. Mandon, 3d.FAB – Université Lyon 1″

3D Medicine & Pharmaceutics Printing Conference Adopts the Fuseami Networking app

3D Medicine & Pharmaceutics Printing Conference Adopts the Fuseami Networking app. To improve business networking at the event, “3D Medicine & Pharmaceutics Printing Conference” is pleased to adopt the fuseami Networking app. fuseami is a revolutionary new mobile app to help you to business network smarter. Discover and connect with those other professionals that are most relevant to you at this conference. Continue reading “3D Medicine & Pharmaceutics Printing Conference Adopts the Fuseami Networking app”